STOCK TITAN

RTW/Dr. Roderick Wong Disclose 55.4M Shares (5.1%) in Zai Lab

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

RTW Investments, LP and Roderick Wong reported shared voting and dispositive power over 55,368,760 ordinary shares of Zai Lab Limited (ZLAB), equal to 5.1% of the class. The percentage is calculated using 1,084,743,860 shares outstanding as of May 2, 2025. The shares are held directly by RTW-managed funds 0 sole voting or dispositive power and 55,368,760 shared voting and dispositive power.

Positive

  • Material stake disclosed: RTW Investments and Roderick Wong report beneficial ownership of 55,368,760 ordinary shares, representing 5.1% of Zai Lab based on 1,084,743,860 shares outstanding as of May 2, 2025.
  • Holdings held by RTW Funds: Shares are directly held by RTW-managed funds, with RTW Investments acting as investment adviser.
  • Filing asserts passive intent: Certification in Item 10 states the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Negative

  • No sole voting or dispositive power: Both RTW Investments and Dr. Wong report 0 sole voting power and 0 sole dispositive power, indicating shared rather than exclusive control over the shares.

Insights

TL;DR: RTW reports a material passive stake of 5.1% in Zai Lab, held via RTW Funds with shared voting and dispositive power.

The filing documents a >5% ownership position (55,368,760 shares) based on 1,084,743,860 outstanding shares as of May 2, 2025, which is material by regulatory standards but is presented as passive and in the ordinary course of business. The position is held by RTW Funds, with RTW Investments and Dr. Wong reporting shared voting and dispositive power and no sole control. For investors, this signals institutional interest without an explicit intent to influence corporate control, per the certification language in Item 10.

TL;DR: A 5.1% reported stake triggers disclosure obligations; the filing asserts passive intent and shows shared, not sole, control.

The Schedule 13G discloses that RTW Investments and Dr. Wong have shared voting and dispositive authority over 55,368,760 shares (5.1%). The filing includes the requisite certification that the securities were acquired and are held in the ordinary course of business and not to influence control, which aligns with Schedule 13G treatment rather than a 13D activist filing. The absence of sole voting or dispositive power is relevant for governance assessment because it indicates no single-party control over voting decisions reported here.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:By Roderick Wong, M.D., Managing Partner
Date:08/14/2025
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:08/14/2025
Exhibit Information

Exhibit 99.1 Joint Filing Agreement

FAQ

What stake does RTW Investments hold in Zai Lab (ZLAB)?

RTW Investments and Roderick Wong report beneficial ownership of 55,368,760 ordinary shares, representing 5.1% of the class.

How was the 5.1% ownership percentage calculated?

The percentage is based on 1,084,743,860 shares outstanding as of May 2, 2025, as reported in Zai Lab's quarterly report filed with the SEC.

Does RTW or Dr. Wong have sole voting or dispositive power over the shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power for both RTW Investments and Roderick Wong, and 55,368,760 shares of shared voting and dispositive power.

Are the shares held for activism or to influence control of Zai Lab?

According to the certification in Item 10, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Who holds the shares on behalf of RTW Investments?

The shares are directly held by the RTW Funds, for which RTW Investments serves as the investment adviser, and RTW Funds have the right to receive dividends or proceeds from sale.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

2.07B
106.96M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI